BioSpace News Archive

Lone Star Bio

Largest-ever clinical study of ketamine therapy shows that at-home model can be a safe, effective treatment for anxiety and depression; 62% fewer patients report suicidal ideation after four sessions

Mindbloom, the leading provider of at-home ketamine therapy, announced Monday the findings of the largest-ever peer-reviewed clinical study of ketamine therapy.

July 18, 2022
·
2 min read
Pharm Country

Seelos Therapeutics Doses First Patient in an Open Label Basket Study of SLS-005 in Amyotrophic Lateral Sclerosis in Australia and Provides an Enrollment Update of its Study on the HEALEY ALS Platform

Seelos Therapeutics, Inc. today announced dosing of the first patient in an open-label basket study of SLS-005.

July 18, 2022
·
5 min read
Radialis PET Imager Receives FDA Clearance

Radialis Inc. announces it has received FDA clearance to market the Radialis PET Imager, an advanced organ-targeted positron emission tomography (PET) system, in the United States.

July 18, 2022
·
2 min read
Bio NC

Mycovia Pharmaceuticals Announces U.S. Availability of VIVJOA™ (oteseconazole) Capsules, the First and Only FDA-Approved Medication for Recurrent Vulvovaginal Candidiasis (Chronic Yeast Infection)

VIVJOA is a new option for postmenopausal and permanently infertile women with recurrent vulvovaginal candidiasis (RVVC).

July 18, 2022
·
6 min read
Heart Rate Monitor Watch Market to Surpass US$ 36.6 Billion by 2032 Amid Rising Incidence of Cardiovascular Disease

Fact.MR – A Market Research and Competitive Intelligence Provider: The global heart rate monitor watch market size is projected to be valued at US$ 36.6 Billion in 2032 and is likely to reach US$ 19.87 Billion in 2022.

July 18, 2022
·
8 min read
Business

Nomination of Dr. Kaushik Majumdar as GPI’s Interim Executive Director

The Global Phosphorus Institute (GPI) announced on June 16th 2022 the designation of Dr. Kaushik Majumdar as Interim Executive Director, with missions of operationalization of current Projects & Activities and further development of GPI.

July 18, 2022
·
2 min read
Policy

COSELA®, the World’s First Comprehensive Myeloprotection Drug against Chemotherapy Damage, Wins Approval in China

On July 13 2022, Simcere Pharmaceuticals announced that the China National Medical Products Administration has conditionally approved COSELA®, an innovative myeloprotection drug jointly developed in China by Simcere and G1 Therapeutics.

July 18, 2022
·
8 min read
Business

Tiziana Life Sciences Appoints Matthew W. Davis, MD, RPh as Chief Medical Officer and Acting Chief Scientific Officer

Tiziana Life Sciences Ltd. announces that it has appointed Matthew Davis, MD, RPh as its Chief Medical Officer and Acting Chief Scientific Officer, effective immediately.

July 18, 2022
·
3 min read
Business

Eagle Pharmaceuticals Appoints Debra M. Hussain as SVP, Head of Commercial

Eagle Pharmaceuticals, Inc. (Nasdaq: EGRX) (“Eagle” or the “Company”) today announced the appointment of Debra M. Hussain as Senior Vice President, Head of Commercial.

July 18, 2022
·
15 min read
Business

MAKO Medical Invests in New Laboratory Automation

MAKO Medical Laboratories is purchasing four additional high-tech liquid handling automation systems after the initial successful evaluation of the first system for the company’s 70,000 square foot laboratory to allow the lab to more than double the COVID-19 testing capacity of a single lab technician in the future.

July 18, 2022
·
4 min read